Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

NCT04285749 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT04285749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04285749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas
Lead sponsor
Case Comprehensive Cancer Center
Phase
Phase 1
Overall status
Withdrawn
Start date
November 6, 2020
Completion date
April 1, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma